These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia. Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019 [TBL] [Abstract][Full Text] [Related]
7. Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background. Rojas EA; Corchete LA; Mateos MV; García-Sanz R; Misiewicz-Krzeminska I; Gutiérrez NC Blood Cancer J; 2019 Nov; 9(12):90. PubMed ID: 31748515 [TBL] [Abstract][Full Text] [Related]
8. Global methylation patterns in primary plasma cell leukemia. Todoerti K; Calice G; Trino S; Simeon V; Lionetti M; Manzoni M; Fabris S; Barbieri M; Pompa A; Baldini L; Bollati V; Zoppoli P; Neri A; Musto P Leuk Res; 2018 Oct; 73():95-102. PubMed ID: 30257227 [TBL] [Abstract][Full Text] [Related]
9. Primary plasma cell leukemia occuring in the young. Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116 [TBL] [Abstract][Full Text] [Related]
10. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. Hofste Op Bruinink D; Kuiper R; van Duin M; Cupedo T; van der Velden VHJ; Hoogenboezem R; van der Holt B; Beverloo HB; Valent ET; Vermeulen M; Gay F; Broijl A; Avet-Loiseau H; Munshi NC; Musto P; Moreau P; Zweegman S; van de Donk NWCJ; Sonneveld P J Clin Oncol; 2022 Sep; 40(27):3132-3150. PubMed ID: 35357885 [TBL] [Abstract][Full Text] [Related]
11. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis]. Jurczyszyn A; Zawirska D; Skotnicki AB Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670 [TBL] [Abstract][Full Text] [Related]
12. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature. Gangadhar P; Ahmed Z; Pai MR; Sandhya I Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic advances in the treatment of primary plasma cell leukemia: a focus on hematopoietic cell transplantation. Nishihori T; Abu Kar SM; Baz R; Alsina M; Harousseau JL; Kharfan-Dabaja MA Biol Blood Marrow Transplant; 2013 Aug; 19(8):1144-51. PubMed ID: 23416092 [TBL] [Abstract][Full Text] [Related]
14. How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells. van de Donk NWCJ J Clin Oncol; 2023 Mar; 41(7):1342-1349. PubMed ID: 36450104 [No Abstract] [Full Text] [Related]
15. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study. Guan J; Ma J; Chen B Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631 [TBL] [Abstract][Full Text] [Related]
16. Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia. Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Sugimoto Y; Kaihara C; Matsuzaki M; Hoshi Y; DeCaprio JA; Anderson KC Clin Cancer Res; 1997 Nov; 3(11):2173-9. PubMed ID: 9815612 [TBL] [Abstract][Full Text] [Related]
17. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia. Cha CH; Park CJ; Huh JR; Chi HS; Suh CW; Kang YK Acta Haematol; 2007; 118(3):178-82. PubMed ID: 17934254 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population. Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277 [TBL] [Abstract][Full Text] [Related]
19. Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma. Lee Y; Yun J; Jeong D; Ryu S; Kwon SR; Yun H; Kim SM; Park JH; Lee DS Leuk Lymphoma; 2022 Feb; 63(2):385-394. PubMed ID: 34592901 [TBL] [Abstract][Full Text] [Related]